Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 3Phase 1 2

Status

Completed 3

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 14Gastrointestinal 5Head & Neck 4Sarcoma 3Genitourinary 3CNS 3Gynecologic 1Dermatologic 1Breast 1

Conditions

Gliosarcoma 2Glioblastoma 2Untreated Childhood Anaplastic Astrocytoma 1Prostatic Neoplasms 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 33Radiotherapy 32pembrolizumab 18Cyclophosphamide 18Irinotecan 16Gemcitabine 16Doxorubicin 16Nivolumab 11Docetaxel 11Sirolimus 10Imatinib Mesylate 10Ifosfamide 10Filgrastim 10Radiation 9Bevacizumab 9Vincristine 8Carboplatin 8pazopanib 7Everolimus 7temsirolimus 6atezolizumab 6Peripheral Blood Stem Cell Transplantation 6Etoposide 6fludarabine phosphate 5Vorinostat 5Specimen Handling 5Radiotherapy, Conformal 5PM 01183 5Ipilimumab 5Erlotinib Hydrochloride 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Gefitinib × Sarcoma × Clear all
NCT00052208 2020-10-30

Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 1/2 Completed
158 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00085566 2016-01-20

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
61 enrolled 8 charts
CNSGenitourinarySarcoma

Brain Neoplasms, Glioblastoma, Prostatic Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

NCT00042991 2014-05-28

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

National Cancer Institute (NCI)

Phase 1/2 Completed
69 enrolled 27 charts
CNSSarcoma

Untreated Childhood Anaplastic Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡